c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EDT
UTC-4 New York
Blue Chip
Log in
Sign up
RDHL
Redhill Biopharma Ltd.
stock
NASDAQ
ADR
At Close
Oct 29, 2026 10:06:42 AM EDT
0.39
USD
-7.921%
(-0.03)
84,475
Pre-market
After-hours
Oct 29, 2026 4:19:30 PM EDT
0.3906
USD
-0.888%
(-0.0035)
0.3700
Bid
0.5600
Ask
0.1900
Spread
Overview
Company
Exchanges
Shorts
News
News
RDHL News
1
/
1
Sep 30, 2026
Day breaks
Oct 19, 2026
08:00 AM EDT
$2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple Myeloma
·
PR Newswire
Oct 1, 2026
06:29 PM EDT
Small Caps Test Their 200-Day Line as Yields Grind Higher and Earnings Season Stirs
·
Financial Post
Sep 30, 2026
04:09 PM EDT
RedHill GAAP EPS of $0.00
·
Seeking Alpha
04:05 PM EDT
RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results
·
PR Newswire
Aug 31, 2026
01:00 PM EDT
Nontuberculous Mycobacterial Infections Market to Showcase Growth at a CAGR of 12.6% During the Forecast Period (2026–2036), Driven by Rising Disease Burden and Emerging Therapies | DelveInsight
·
GlobeNewswire Inc.